{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T20:46:35Z","timestamp":1764103595339,"version":"3.41.2"},"reference-count":17,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Chromosome 9p21.3 is a locus associated with a rare autosomal dominant cancer predisposition syndrome characterized by early-onset melanoma and a broad spectrum of neural system tumors. Two major tumor-suppressor genes, cyclin-dependent kinase inhibitor 2A and 2B (<jats:italic>CDKN2A<\/jats:italic> and <jats:italic>CDKN2B<\/jats:italic>), as well as a large non-coding RNA <jats:italic>ANRIL<\/jats:italic>, are often co-deleted in the core region. Herein, we report a pregnant woman who had developed more than 20 plexiform neurofibromas since the age of 13 and experienced 11 times of surgical resections. No melanoma or other tumors were found. A germline 9p21.3 deletion involving <jats:italic>CDKN2A<\/jats:italic> and the first exon of <jats:italic>ANRIL<\/jats:italic>, but not <jats:italic>CDKN2B<\/jats:italic>, was identified by whole exome sequencing (WES) and confirmed by quantitative PCR. Prenatal diagnosis was performed through copy number variation-sequencing (CNV-seq), and the pregnancy was terminated with informed choice for an affected fetus. All the eight cases carrying germline 9p21.3 deletions were reviewed for genotype\u2013phenotype correlation, showing that our case with the smallest deletion had plexiform neurofibroma only, and the two cases of Eastern Asian origin had no melanoma. Our data highlight 9p21.3 deletion as a potential differential diagnosis for neurofibroma and emphasize the importance of CNV analysis on the WES data wherein small deletions might be easily overlooked.<\/jats:p>","DOI":"10.3389\/fonc.2025.1437093","type":"journal-article","created":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T09:02:03Z","timestamp":1739955723000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Case report: The smallest 9p21.3 microdeletion involving CDKN2A but not CDKN2B causes multiple plexiform neurofibromas"],"prefix":"10.3389","volume":"15","author":[{"given":"Yuanyuan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiming","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuang","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoliang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/0092-8674(95)90214-7","article-title":"Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest","volume":"83","author":"Quelle","year":"1995","journal-title":"Cell"},{"key":"B2","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/S0959-437X(99)80004-5","article-title":"The INK4A\/ARF locus and its two gene products","volume":"9","author":"Sharpless","year":"1999","journal-title":"Curr Opin Genet Dev"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-2004","article-title":"Characterization of a germ-line deletion, including the entire INK4\/ARF locus, in a melanoma-neural system tumor family: identification of ANRIL, an antisense noncoding RNA whose expression coclusters with ARF","volume":"67","author":"Pasmant","year":"2007","journal-title":"Cancer Res"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00405","article-title":"ANRIL: A lncRNA at the CDKN2A\/B Locus With Roles in Cancer and Metabolic Disease","volume":"9","author":"Kong","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B5","first-page":"96","article-title":"Molecular definition of a chromosome 9p21 germ-line deletion in a woman with multiple melanomas and a plexiform neurofibroma: implications for 9p tumor-suppressor gene(s)","volume":"53","author":"Petty","year":"1993","journal-title":"Am J Hum Genet"},{"key":"B6","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/1471-2350-15-59","article-title":"A large de novo 9p21.3 deletion in a girl affected by astrocytoma and multiple melanoma","volume":"15","author":"Frigerio","year":"2014","journal-title":"BMC Med Genet"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2015-103446","article-title":"An interstitial deletion within 9p21.3 and extending beyond CDKN2A predisposes to melanoma, neural system tumours and possible haematological Malignancies","volume":"53","author":"Baker","year":"2016","journal-title":"J Med Genet"},{"key":"B8","doi-asserted-by":"publisher","first-page":"16015","DOI":"10.1038\/npjgenmed.2016.15","article-title":"Germline hemizygous deletion of CDKN2A-CDKN2B locus in a patient presenting with Li-Fraumeni syndrome","volume":"1","author":"Chan","year":"2016","journal-title":"NPJ Genom Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.5414\/NP301022","article-title":"Familial melanoma-astrocytoma syndrome: synchronous diffuse astrocytoma and pleomorphic xanthoastrocytoma in a patient with germline CDKN2A\/B deletion and a significant family history","volume":"36","author":"Chan","year":"2017","journal-title":"Clin Neuropathol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"a006164","DOI":"10.1101\/mcs.a006164","article-title":"9p21.3 Microdeletion involving CDKN2A\/2B in a young patient with multiple primary cancers and review of the literature","volume":"8","author":"Jensen","year":"2022","journal-title":"Cold Spring Harb Mol Case Stud"},{"key":"B11","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1093\/jnci\/94.12.894","article-title":"Geographical variation in the penetrance of CDKN2A mutations for melanoma","volume":"94","author":"Bishop","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.2016.175.issue-4","article-title":"CDKN2A mutations with p14 loss predisposing to multiple nerve sheath tumours, melanoma, dysplastic naevi and internal Malignancies: a case series and review of the literature","volume":"175","author":"Sargen","year":"2016","journal-title":"Br J Dermatol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.1136\/jmg.40.8.e102","article-title":"Identification of a splice acceptor site mutation in p16INK4A\/p14ARF within a breast cancer, melanoma, neurofibroma prone kindred","volume":"40","author":"Prowse","year":"2003","journal-title":"J Med Genet"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2016.08.009","article-title":"p15 expression differentiates nevus from melanoma","volume":"186","author":"Taylor","year":"2016","journal-title":"Am J Pathol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"115627","DOI":"10.1016\/j.bcp.2023.115627","article-title":"CDKN2B-AS1 as a novel therapeutic target in cancer: Mechanism and clinical perspective","volume":"213","author":"Hjazi","year":"2023","journal-title":"Biochem Pharmacol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/humu.2018.39.issue-8","article-title":"Analysis of intratumor heterogeneity in Neurofibromatosis type 1 plexiform neurofibromas and neurofibromas with atypical features: Correlating histological and genomic findings","volume":"39","author":"Carri\u00f3","year":"2018","journal-title":"Hum Mutat"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noy013","article-title":"The characteristics of 76 atypical neurofibromas as precursors to neurofibromatosis 1 associated Malignant peripheral nerve sheath tumors","volume":"20","author":"Higham","year":"2018","journal-title":"Neuro Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1437093\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T09:02:07Z","timestamp":1739955727000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1437093\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,19]]},"references-count":17,"alternative-id":["10.3389\/fonc.2025.1437093"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1437093","relation":{},"ISSN":["2234-943X"],"issn-type":[{"type":"electronic","value":"2234-943X"}],"subject":[],"published":{"date-parts":[[2025,2,19]]},"article-number":"1437093"}}